Immune evasion as a pathogenic mechanism of varicella zoster virus

Arvin, 1995, Varicella-zoster virus, 2547 Cohen, 1995, Varicella zoster virus and its replication, 2525 Arvin, 1996, Immune responses to varicella-zoster virus, Infect Dis Clin North Am, 10, 529, 10.1016/S0891-5520(05)70312-3 Zhang, 1994, Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures, Clin Exp Immunol, 98, 128, 10.1111/j.1365-2249.1994.tb06618.x Heyward, 1989, Phenotype, cytotoxic, and helper functions of T cells from varicella zoster virus stimulated cultures of human lymphocytes, Viral Immunol, 2, 175, 10.1089/vim.1989.2.175 Hayward, 1986, Specific lysis of varicella zoster virus-infected B lymphoblasts by human T cells, J Virol, 58, 179, 10.1128/JVI.58.1.179-184.1986 Huang, 1992, Specific lysis of targets expressing varicella-zoster virus gpI or gpIV by CD4 human T-cell clones, J Virol, 66, 2664, 10.1128/JVI.66.5.2664-2669.1992 Sharp, 1992, Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine, J Infect Dis, 165, 852, 10.1093/infdis/165.5.852 A, Abendroth, I, Lin, H, Ploegh, A, M, Arvin, 1999, 24th International Herpesvirus Workshop, Cambridge, MIT Abendroth, 2000, Modulation of major histocompatibility complex class II expression by varicella zoster virus, J Virol, 74, 1900, 10.1128/JVI.74.4.1900-1907.2000 Roizman, 1995, Herpes simplex viruses and their replication McGeoch, 1995, Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses, J Mol Biol, 247, 443, 10.1006/jmbi.1995.0152 Davison, 1986, The complete DNA sequence of varicella-zoster virus, J Gen Virol, 67, 1759, 10.1099/0022-1317-67-9-1759 Ziegler, 1997, A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments, Immunity, 6, 57, 10.1016/S1074-7613(00)80242-3 Jones, 1995, Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains, J Virol, 69, 4830, 10.1128/JVI.69.8.4830-4841.1995 Jones, 1996, Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains, Proc Natl Acad Sci USA, 93, 11327, 10.1073/pnas.93.21.11327 Wiertz, 1996, The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol, Cell, 84, 769, 10.1016/S0092-8674(00)81054-5 Jones, 1997, Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains, J Virol, 71, 2970, 10.1128/JVI.71.4.2970-2979.1997 Levitskaya, 1997, Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epistein–Barr virus nuclear antigen, Proc Natl Acad Sci, 94, 12616, 10.1073/pnas.94.23.12616 Nataraj, 1997, Boivine herpesvirus 1 downregulates the expression of bovine MHC class I molecules, Viral Immunol, 10, 21, 10.1089/vim.1997.10.21 Sparks-Thissen, 1999, Differential regulation of Dk and Kk major histocompatibility complex class I proteins on the cell surface after infection of murine cells by pseudorabies virus, J Virol, 73, 5748, 10.1128/JVI.73.7.5748-5756.1999 Cohen, 1998, Infection of cells with varicella-zoster virus down-regulates surface expression of class I major histocompatibility complex antigens, J Infect Dis, 177, 1390, 10.1086/517821 Moffat, 1995, Tropism of varicella-zoster virus for human CD4 and CD8 T lymphocytes and epidermal cells in SCID-hu mice, J Virol, 69, 5236, 10.1128/JVI.69.9.5236-5242.1995 Moffat, 1998, Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse, J Virol, 72, 965, 10.1128/JVI.72.2.965-974.1998 Moffat, 1998, The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse, Proc Natl Acad Sci USA, 95, 11969, 10.1073/pnas.95.20.11969 Grose, 1981, Variation on a theme by Fenner, Pediatrics, 68, 735, 10.1542/peds.68.5.735 Gilden, 1992, Herpes zoster: pathogenesis and latency, 19 Lowry, 1992, Investigation of the pathogenesis of varicella-zoster virus infection in guinea pigs using polymerase chain reaction, J Infect Dis, 167, 78, 10.1093/infdis/167.1.78 Burnell, 1999, Viral gene expression in rat trigeminal ganglia following neonatal infection with varicella-zoster virus, J Med Virol, 58, 285 Lungu, 1995, Reactivated and latent varicella-zoster virus in human dorsal root ganglia, Proc Natl Acad Sci USA, 92, 10980, 10.1073/pnas.92.24.10980 Cohrs, 1996, Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA, J Virol, 70, 2789, 10.1128/JVI.70.5.2789-2796.1996 Lungu, 1998, Aberrant intracellular localization of varicella-zoster virus regulatory proteins during latency, Proc Natl Acad Sci USA, 95, 7080, 10.1073/pnas.95.12.7080 Pevenstein, 1999, Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia, J Virol, 73, 10514, 10.1128/JVI.73.12.10514-10518.1999 A, Hata, L, Zerboni, M, Sommer, A, Kasper, A, M, Krensky, A, M, Arvin, The antiviral activity of granulysin, (Submitted) Arvin, 1998, Varicella-zoster virus: Virologic and immunologic aspects of persistent infection, 183 Jenkins, 1998, Interleukin (IL)-10, IL-12, and interferon- γ production in primary and memory immune responses to varicella-zoster virus, J Infect Dis, 178, 940, 10.1086/515702 Camitta, 1994, Use of irradiated lymphocytes from immune donors for treatment of disseminated varicella [see comments], J Pediatr, 124, 593, 10.1016/S0022-3476(05)83139-7 Levin, 1996, The varicella vaccine. Prevention of herpes zoster, Infect Dis Clin North Am, 10, 657, 10.1016/S0891-5520(05)70319-6 Webster, 1989, Titration of IgG antibodies against varicella zoster virus before bone marrow transplantation is not predictive of future zoster, J Med Virol, 27, 117, 10.1002/jmv.1890270209 Hengel, 1997, A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter, Immunity, 6, 623, 10.1016/S1074-7613(00)80350-7 York, 1994, A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8 T lymphocytes, Cell, 77, 525, 10.1016/0092-8674(94)90215-1 Hill, 1995, Herpes simplex virus turns off the TAP to evade host immunity, Nature, 375, 411, 10.1038/375411a0 Fruh, 1995, A viral inhibitor of peptide transporters for antigen presentation, Nature, 375, 415, 10.1038/375415a0 Fruh, 1999, A comparison of viral immune escape strategies targeting the MHC class I assembly pathway, Immunol Rev, 168, 157, 10.1111/j.1600-065X.1999.tb01290.x Ahn, 1996, Human cytomegalovirus inhibits antigen presentation by a sequential multistep process, Proc Natl Acad Sci USA, 93, 10990, 10.1073/pnas.93.20.10990 Ahn, 1997, The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP, Immunity, 6, 613, 10.1016/S1074-7613(00)80349-0 Ahn, 1996, Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47, EMBO J, 15, 3247, 10.1002/j.1460-2075.1996.tb00689.x Tomazin, 1996, Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP, EMBO J, 15, 3256, 10.1002/j.1460-2075.1996.tb00690.x Galocha, 1997, The active site of ICP47, a herpes simplex virus-encoded inhibitor of major histocompatibility complex (MHC)-encoded peptide transport associated with antigen processing (TAP), maps to the NH2-terminal 35 residues, J Exp Med, 185, 1565, 10.1084/jem.185.9.1565 Hengel, 1996, Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly, J Gen Virol, 77, 2287, 10.1099/0022-1317-77-9-2287 Wiertz, 1996, The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol, Cell, 84, 769, 10.1016/S0092-8674(00)81054-5 Machold, 1997, The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex, J Exp Med, 185, 363, 10.1084/jem.185.2.363 Kleijnen, 1997, A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface, EMBO J, 16, 685, 10.1093/emboj/16.4.685 Reusch, 1999, A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation, EMBO J, 18, 1081, 10.1093/emboj/18.4.1081 Chapman, 1998, Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog, J Virol, 72, 460, 10.1128/JVI.72.1.460-466.1998 Cohen, 1999, The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells, Immunity, 10, 661, 10.1016/S1074-7613(00)80065-5 Miller, 1999, Viral effects on antigen processing, Curr Opin Immunol, 11, 94, 10.1016/S0952-7915(99)80017-X Rinaldo, 1994, Modulation of major histocompatibility complex antigen expression by viral infection, Am J Pathol, 144, 637 Collins, 1984, Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts, Proc Natl Acad Sci USA, 81, 4917, 10.1073/pnas.81.15.4917 Pober, 1983, Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon, Nature, 305, 726, 10.1038/305726a0 Chang, 1994, Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes, J Exp Med, 180, 1367, 10.1084/jem.180.4.1367 Steimle, 1994, Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA, Science, 265, 106, 10.1126/science.8016643 Hobart, 1997, IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo, J Immunol, 158, 4260, 10.4049/jimmunol.158.9.4260 Meraz, 1996, Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway, Cell, 84, 431, 10.1016/S0092-8674(00)81288-X Piskurich, 1998, Identification of distinct regions of 5′flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene, J Immunol, 160, 233, 10.4049/jimmunol.160.1.233 Miller, 1998, Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway, J Exp Med, 187, 675, 10.1084/jem.187.5.675 Leonard, 1997, Restoration of interferon responses of adenovirus E1A-expressing HT1080 cell lines by over expression of p48 protein, J Virol, 71, 5095, 10.1128/JVI.71.7.5095-5101.1997 Tomazin, 1999, Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+T cells, Nat Med, 5, 1039, 10.1038/12478 Mikloska, 1996, Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma, J Infect Dis, 173, 7, 10.1093/infdis/173.1.7 Heise, 1998, Murine cytomegalovirus infection inhibits IFN gamma-induced MHC class II expression on macrophages: the role of type I interferon, Virology, 241, 331, 10.1006/viro.1997.8969